Alternative to Stripe for peptides: what actually approves and keeps approving
- Stripe bans peptides under its Restricted Businesses list — there is no workaround, only alternatives.
- Realistic alternatives: Authorize.net via a nutra-specialist ISO, NMI, offshore acquirer, or consolidated parent account for multi-brand operators.
- Expect 3.5-4.5% effective rate and a 10-20% reserve for the first 180 days.
On this page
If you sell peptides and you are searching for a Stripe alternative, you already know Stripe shut you down or will. The real question is not "Stripe or what" — it is "what alternative will keep approving me in month 6, month 12, month 24, when I am doing double the volume?" That is a different conversation and the honest answer depends on how many brands you run.
1. Why "alternative to Stripe" is not the same as "processor for peptides"
Stripe is a payment facilitator (payfac). That means every Stripe account sits on top of a shared merchant-of-record with blanket MCC categorization. When peptides violate the blanket policy, you are out — no appeal. Real peptide processors are structured differently: you get your own MID (merchant identifier), your own underwriting, your own chargeback ratio, and the relationship is between your LLC and the acquirer — not between your LLC and a payfac middleman.
2. The realistic alternatives (ranked by accessibility)
Authorize.net through a nutra-specialist ISO
Most common peptide landing spot. The ISOs that regularly approve peptide applicants:
- EasyPayDirect — probably the loudest nutra/peptide advertiser, 3.5-4.5% effective, 10-15% reserve 180 days.
- PayKings — similar rates, tighter SKU scrutiny.
- Durango Merchant Services — slightly higher reserves for new accounts.
- Corepay, Soar Payments, High Risk Pay — similar tier, shop the contract terms.
All charge PCI fees, monthly statement fees, and most have 2-3 year contracts with early termination fees of $250-$500. Read the termination clause before you sign.
NMI gateway
NMI is Authorize.net's main competitor as a gateway and some peptide-friendly ISOs prefer NMI because the fraud tooling is more aggressive. Rates and reserves similar.
Offshore acquirers
For operators over $500k/month, European (Emerchantpay, Paynetics) and Canadian (Global Payments Canada with the right structure) acquirers expand capacity but add 1-2% cross-border fees and currency friction.
Parent-account orchestration (for multi-brand operators)
If you run 3+ peptide brands under one parent entity, the ISO-per-brand model means N underwriting cycles, N reserve pools, N sets of rate negotiations. A parent merchant account with orchestrated sub-brand descriptors runs every brand under one MID while preserving the sub-brand name on the statement descriptor. That is what multiflow orchestrates.
3. What Stripe was actually doing for you (so you replace all of it, not just the charges)
Stripe was not just a processor. It was your dispute dashboard, your subscription engine, your fraud filter, your 3DS handler, your Apple Pay/Google Pay rails, your tax reporting feed, and your customer card-vault. Your replacement stack needs all of that. Gaps we see operators forget:
- Chargeback alerts (Ethoca/Verifi) are not included in most ISO deals — wire them separately.
- 3DS/SCA for EU customers — confirm the gateway supports it.
- Vaulted card migration — Stripe will release tokens to a compliant destination on PCI-validated request. Start this in week 1.
- Subscription billing — your existing billing engine (Chargebee, Recharge, custom) needs to speak to the new gateway, not to Stripe.
4. Rates you should expect (and push back on)
Starter peptide rate: 3.8-4.5% effective. After 6-12 months of clean processing you can renegotiate to 3.2-3.8%. Anyone quoting 2.9% all-in on a new peptide account is running a teaser — read month-6 rate on the sheet.
5. Reserves: what to accept and what to fight
10-15% rolling reserve for 180 days is the peptide industry floor right now. Upfront cash reserves ($10-25k) sometimes replace or supplement. Fight: reserve percentages above 20%, reserve duration longer than 180 days, or "upfront plus rolling" without a release schedule in writing.
6. The chargeback ratio conversation
Ask literally: "What monthly chargeback ratio pauses my account? What ratio ends the relationship?" Good answer: 0.9% pause, 1.2% review. Bad answer: "We don't have a hard number." Walk from vague.
7. What not to do
- Don't apply under a new EIN and paper over the peptide SKUs — underwriters fingerprint aggressively and repeat closures add to your file.
- Don't apply to 8 ISOs at once — multiple declines in 30 days flag you as a pattern.
- Don't sign a 3-year contract without a volume-growth renegotiation clause.
- Don't pay upfront "consulting fees" to be placed with the same ISO you could apply to directly.
8. Our honest recommendation
Single-brand, under $100k/mo: apply to EasyPayDirect and one other nutra ISO in parallel, compare contracts, sign the better deal. Expect 10 business days.
Multi-brand, 3+ peptide brands, or building toward a holding-company model: the parent-account orchestration math usually wins. Apply in 12 questions and we will send an honest sizing — including cases where the answer is "stay on an ISO, you are not there yet."
9. One more thing — your MATCH exposure
If Stripe shut you down for chargebacks or fraud (not just category), the bigger risk is a MATCH listing. Pull your status before applying anywhere. Our MATCH playbook covers the process.